DNLIDenali Therapeutics Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 14328
Ticker: DNLI
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2017-12-08
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: DNLI

Detail

Enriched 2026-08-14 20:47

Market cap: $4,039,343,873.81
Shares outstanding (class): 159,847,403
Shares outstanding (weighted): 159,847,403
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 507
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.denalitherapeutics.com
Description: Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Market cap and share counts drift.

Funds holding this security

135 funds · 140 positions · $673.75M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$81.44M	0.00%	4,241,645 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$66.65M	0.09%	3,471,378 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$59.74M	0.04%	3,111,480 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$54.35M	0.73%	2,830,854 NS	FIGI
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$44.75M	0.55%	2,330,622 NS	FIGI
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$42.41M	0.05%	2,208,811 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$33.37M	0.09%	1,737,893 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$31.79M	0.04%	1,655,668 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$27.07M	0.29%	1,409,636 NS	FIGI
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$24.47M	0.56%	1,274,515 NS	FIGI
abrdn Healthcare Investors —	—	$22.84M	2.01%	1,189,730 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$22.07M	0.18%	1,149,603 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$20.26M	0.25%	1,055,210 NS	FIGI
Artisan International Small-Mid Fund Artisan Partners Funds Inc.	—	$13.12M	0.49%	683,443 NS	FIGI
abrdn Life Sciences Investors —	—	$12.76M	2.28%	664,716 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERDNLI
FIGI_COMPOSITEBBG008P7F869
FIGI_SHARE_CLASSBBG008P7F878
CIK0001714899
ISINUS24823R1059
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Denali Therapeutics is a biopharmaceutical company developing treatments for neurodegenerative diseases, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.